Eli Lilly and Co
F:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
C
|
Caterpillar Inc
XMUN:CAT1
|
US |
|
LG Electronics Inc
KRX:066570
|
KR |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
M
|
Mondelez International Inc
XMUN:KTF
|
US |
|
N
|
News Corp
F:NC0
|
US |
|
E
|
Experian PLC
SWB:J2B
|
IE |
|
R
|
Royal Bank of Canada
XMUN:RYC
|
CA |
|
B
|
Bureau Veritas SA
F:4BV
|
FR |
|
C
|
China Resources Land Ltd
SWB:CHZ
|
HK |
|
C
|
Coca-Cola HBC AG
F:C0Q
|
CH |
|
L
|
Legrand SA
SWB:LRC
|
FR |
|
S
|
Sanofi SA
SWB:SNW
|
FR |
|
L
|
Lockheed Martin Corp
DUS:LOM
|
US |
|
E
|
Ecolab Inc
BMV:ECL
|
US |
|
D
|
Danone SA
DUS:BSN
|
FR |
|
Singapore Airlines Ltd
F:SIA
|
SG |
|
D
|
Duke Energy Corp
F:D2MN
|
US |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
Aena SME SA
F:A441
|
ES |
|
C
|
Compass Group PLC
SWB:XGR2
|
UK |
|
D
|
Dover Corp
DUS:DOV
|
US |
|
I
|
Ispire Technology Inc
NASDAQ:ISPR
|
US |
|
Coca-Cola HBC AG
F:CCKC
|
CH |
Bankruptcy Probability
Eli Lilly and Co's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eli Lilly and Co Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
372.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
361.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eli Lilly and Co's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eli Lilly and Co has total debt of 53.1B USD. This includes both short-term (5.3B USD) and long-term (47.9B USD) debt.
You can find a full breakdown on its Balance Sheet.